Accessibility Menu
 
Trajan Group logo

Trajan Group

(ASX) TRJ

Current Price$0.40
Market Cap$60.27M
Since IPO (2021)-80%
5 YearN/A
1 Year-55%
1 Month-20%

Trajan Group Financials at a Glance

Market Cap

$60.27M

Revenue (TTM)

$329.13M

Net Income (TTM)

$29.86M

EPS (TTM)

$-0.01

P/E Ratio

-43.89

Dividend

$0.00

Beta (Volatility)

0.01 (Low)

Price

$0.40

Volume

60,649

Open

$0.40

Previous Close

$0.40

Daily Range

$0.39 - $0.40

52-Week Range

$0.39 - $0.97

TRJ News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Trajan Group

Industry

Life Sciences Tools and Services

CEO

Stephen Andrew Tomisich

Headquarters

Ringwood, VIC 3134, AU

TRJ Financials

Key Financial Metrics (TTM)

Gross Margin

25%

Operating Margin

0%

Net Income Margin

-1%

Return on Equity

-1%

Return on Capital

0%

Return on Assets

-1%

Earnings Yield

-2.28%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$60.27M

Shares Outstanding

152.59M

Volume

60.65K

Short Interest

0.00%

Avg. Volume

39.62K

Financials (TTM)

Gross Profit

$63.47M

Operating Income

$3.48M

EBITDA

$8.14M

Operating Cash Flow

$10.83M

Capital Expenditure

$4.09M

Free Cash Flow

$6.74M

Cash & ST Invst.

$11.85M

Total Debt

$55.49M

Trajan Group Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$84.06M

+10.0%

Gross Profit

$8.13M

+50.4%

Gross Margin

9.67%

N/A

Market Cap

$60.27M

N/A

Market Cap/Employee

$100.46K

N/A

Employees

600

N/A

Net Income

$449.00K

-18.8%

EBITDA

$4.32M

+105.2%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Net Cash

$56.59M

-16.4%

Accounts Receivable

$21.37M

-4.4%

Inventory

$30.03M

+7.9%

Long Term Debt

$66.20M

+53.7%

Short Term Debt

$3.17M

-81.1%

Return on Assets

-0.72%

N/A

Return on Invested Capital

0.47%

N/A

Free Cash Flow

$1.38M

-171.9%

Operating Cash Flow

$156.00K

-104.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
EZZ.AXEZZ Life Science Holdings Limited
$0.83+0.00%
ILA.AXIsland Pharmaceuticals Limited
$0.37+1.37%
ALA.AXArovella Therapeutics Limited
$0.09+29.17%
AHC.AXAustco Healthcare Limited
$0.34-1.43%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$48.96+0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.45+0.02%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$67.86-0.02%
NOKNokia
$9.55+0.01%

Questions About TRJ

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.